PhD, let’s be clear, I am NOT trying to convince ANYONE to invest one penny. Never have, never will, it’s not my thing. We are all just debating the pros and cons of this company. I tire of those who say the company is a scam where there is ample evidence that it is not.
Scams don’t have doctors treating with patented, trademarked procedures. Is the company viable is the only question? We will see, I think it is.
Based on all the delays and missteps there have been, and the horrible effects their choice of financing has been, we are at the rock bottom. Depending on how the note holders dump or hold IF the RS goes into effect will make a huge difference. Wolf is right about that. We all know a RS is usually a death sentence in the OTC, however CMTH is not your normal OTC for the reasons I mentioned above.
I still hold my faith because of the IP. I think the big boy on the block is StemSpine ......and it’s ready. I think many doctors have been waiting on the clinical trial and it’s out too.
Everything will change soon if it’s gonna change. The ball is in CMTH’s court finally.
Market Data 
Markets 
AI
